Clinical Trials List
Protocol Number1438-0011
Not yet recruiting
2026-05-01 - 2030-12-31
Phase III
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- 姜乃榕 無
- San-Chi Chen 無
- 唐振育 無
- Yi-Ping Hung 無
- 邱乃祈 無
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14 participants
-
Global
390 participants
